ENTRY       D03844            Mixture   Drug
NAME        Phenytoin, phenobarbital and caffeine and sodium benzoate;
            Hydantol F (TN)
COMPONENT   Phenytoin [DR:D00512], Phenobarbital [DR:D00506], Caffeine and sodium benzoate [DR:D02409]
CLASS       Metabolizing enzyme substrate
             DG02919  CYP2B6 substrate
             DG01642  CYP2C9 substrate
             DG01639  CYP2C19 substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      ATC code: N03AB52
EFFICACY    Antiepileptic
METABOLISM  Enzyme: CYP2C9 [HSA:1559], CYP2C19 [HSA:1557], CYP2B6 [HSA:1555], CYP3A [HSA:1576 1577 1551]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AB Hydantoin derivatives
                 N03AB52 Phenytoin, combinations
                  D03844  Phenytoin, phenobarbital and caffeine and sodium benzoate
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG02919  CYP2B6 substrate
               D03844  Phenytoin, phenobarbital and caffeine and sodium benzoate
              DG01642  CYP2C9 substrate
               D03844  Phenytoin, phenobarbital and caffeine and sodium benzoate
              DG01639  CYP2C19 substrate
               D03844  Phenytoin, phenobarbital and caffeine and sodium benzoate
              DG01633  CYP3A/CYP3A4 substrate
               D03844  Phenytoin, phenobarbital and caffeine and sodium benzoate
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D03844
DBLINKS     PubChem: 17397930
///
